Ernexa Therapeutics Inc. (ERNAW) — DEF 14A Filings
All DEF 14A filings from Ernexa Therapeutics Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Ernexa Therapeutics Inc. Files 2024 Annual Proxy Statement
— Apr 14, 2025 Risk: low
Ernexa Therapeutics Inc. filed its DEF 14A on April 14, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and board -
Eterna Therapeutics Files Definitive Proxy Statement
— Oct 7, 2024 Risk: low
Eterna Therapeutics Inc. filed a Definitive Proxy Statement (DEF 14A) on October 7, 2024. The filing concerns the company's proxy materials, which are typically
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX